FindMyKOL
Clinical trialNCT02386176CompletedObservational

Assessment of Automated Breast Ultrasound

NCT02386176 is an observational study sponsored by University of Pittsburgh. As of 21 Nov 2026, it is completed. It studies Breast Cancer. The registry lists an enrollment of 598 participants at 1 site in 1 country. The registry lists a start date of 31 Aug 2015 and a primary completion date of 31 Mar 2020.

SponsorUniversity of Pittsburgh →Enrollment598Breast Cancer
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02386176
FieldValue
Registry IDNCT02386176
StatusCompleted
Study typeObservational study
Lead sponsorUniversity of Pittsburgh
Enrollment598
Registered sites1
Countries1
ConditionsBreast Cancer
Start31 Aug 2015
Primary completion31 Mar 2020
Study completion31 Mar 2020
Last update posted6 Apr 2020

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The investigators are interested in assessing the value of and comparing the use of automated breast ultrasound (ABUS) (either as a primary screening approach or as a supplementary procedure) with digital breast tomosynthesis (DBT). The purpose of this project is to perform a preliminary prospective study on women who are most likely to benefit from the use of ABUS and/or DBT (or a combination of both) in the screening environment.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Pennsylvania, United States1 site
  • Magee-Womens Hospital

    Pittsburgh

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvania: 1 sitePA1New JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02386176

Each answer restates registry values shown on this page.

What is NCT02386176?

NCT02386176 is an observational study sponsored by University of Pittsburgh. It studies Breast Cancer.

Who leads NCT02386176?

The registry names Denise M Chough, MD (principal investigator, University of Pittsburgh) as the overall official.

Where does NCT02386176 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT02386176 end?

The registry lists a primary completion date of 31 Mar 2020 and a study completion date of 31 Mar 2020. The sponsor last updated the record on 6 Apr 2020.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.